Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-08 9:54 pm Unchanged |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 4,267,564 8.800% |
0 (Unchanged) |
Filing History |
| 2021-01-28 8:30 pm Sale |
2021-01-22 | 13D | PREVAIL THERAPEUTICS INC PRVL |
ORBIMED ADVISORS LLC | 0 0.000% |
-13,822,463 (Position Closed) |
Filing History |
| 2021-01-28 1:48 pm Unchanged |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 5,947,323 11.200% |
0 (Unchanged) |
Filing History |
| 2021-01-21 4:46 pm Purchase |
2021-01-12 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 29,853,364 9.100% |
29,853,364 (New Position) |
Filing History |
| 2021-01-13 5:34 pm Purchase |
2021-01-11 | 13D | Prelude Therapeutics Incorporated PRLD |
ORBIMED ADVISORS LLC | 14,847,077 31.900% |
41,700 (+0.28%) |
Filing History |
| 2020-12-30 4:27 pm Sale |
2020-12-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 3,216,206 13.400% |
-600,000 (-15.72%) |
Filing History |
| 2020-12-11 4:47 pm Purchase |
2020-12-03 | 13D | ARS Pharmaceuticals, Inc. SPRY |
ORBIMED ADVISORS LLC | 7,788,511 22.400% |
7,788,511 (New Position) |
Filing History |
| 2020-12-11 4:39 pm Purchase |
2020-12-02 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 3,397,929 7.800% |
3,397,929 (New Position) |
Filing History |
| 2020-11-20 4:32 pm Unchanged |
2020-11-19 | 13D | Keros Therapeutics, Inc. KROS |
ORBIMED ADVISORS LLC | 1,268,734 5.500% |
0 (Unchanged) |
Filing History |
| 2020-11-18 2:42 pm Unchanged |
2020-11-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 7.800% |
0 (Unchanged) |
Filing History |
| 2020-11-12 5:15 pm Purchase |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
ORBIMED ADVISORS LLC | 346,263 11.000% |
346,263 (New Position) |
Filing History |
| 2020-11-06 5:12 pm Purchase |
2020-10-29 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 110,858 11.300% |
110,858 (New Position) |
Filing History |
| 2020-10-22 8:40 pm Unchanged |
2020-10-22 | 13D | BELLUS Health Inc. BLU |
ORBIMED ADVISORS LLC | 3,954,800 5.200% |
0 (Unchanged) |
Filing History |
| 2020-10-13 9:14 pm Unchanged |
2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 7,406,307 15.500% |
0 (Unchanged) |
Filing History |
| 2020-10-07 5:08 pm Purchase |
2020-10-02 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 4,267,564 9.900% |
200,000 (+4.92%) |
Filing History |
| 2020-10-06 5:16 pm Purchase |
2020-10-01 | 13D | ContextLogic Inc. LOGC |
ORBIMED ADVISORS LLC | 137,566 13.000% |
21,307 (+18.33%) |
Filing History |
| 2020-10-05 5:28 pm Purchase |
2020-09-25 | 13D | Graybug Vision, Inc. GRAY |
ORBIMED ADVISORS LLC | 297,382 20.700% |
297,382 (New Position) |
Filing History |
| 2020-10-05 5:27 pm Purchase |
2020-10-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,810,381 94.800% |
58,796,060 (+419.54%) |
Filing History |
| 2020-10-05 5:23 pm Purchase |
2020-09-25 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,589,330 14.700% |
6,589,330 (New Position) |
Filing History |
| 2020-10-05 5:17 pm Purchase |
2020-09-25 | 13D | Prelude Therapeutics Incorporated PRLD |
ORBIMED ADVISORS LLC | 14,805,377 33.900% |
14,805,377 (New Position) |
Filing History |